CA3232086A1 - Prodrugs of axitinib - Google Patents
Prodrugs of axitinib Download PDFInfo
- Publication number
- CA3232086A1 CA3232086A1 CA3232086A CA3232086A CA3232086A1 CA 3232086 A1 CA3232086 A1 CA 3232086A1 CA 3232086 A CA3232086 A CA 3232086A CA 3232086 A CA3232086 A CA 3232086A CA 3232086 A1 CA3232086 A1 CA 3232086A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- ch2oco
- certain embodiments
- pharmaceutical composition
- condition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255998P | 2021-10-15 | 2021-10-15 | |
| US63/255,998 | 2021-10-15 | ||
| PCT/US2022/046750 WO2023064578A1 (en) | 2021-10-15 | 2022-10-14 | Prodrugs of axitinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3232086A1 true CA3232086A1 (en) | 2023-04-20 |
Family
ID=85987895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3232086A Pending CA3232086A1 (en) | 2021-10-15 | 2022-10-14 | Prodrugs of axitinib |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250092013A1 (enExample) |
| EP (1) | EP4416132A4 (enExample) |
| JP (1) | JP2024537839A (enExample) |
| CN (1) | CN118119599A (enExample) |
| AU (1) | AU2022362310A1 (enExample) |
| CA (1) | CA3232086A1 (enExample) |
| MX (1) | MX2024003968A (enExample) |
| WO (1) | WO2023064578A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024081410A1 (en) * | 2022-10-14 | 2024-04-18 | Ocular Therapeutix, Inc. | Prodrugs, formulations and methods thereof |
| AU2024251447A1 (en) | 2023-04-11 | 2025-08-21 | Ocular Therapeutix, Inc. | Ocular implant comprising axitinib polymorph iv |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5721949B2 (ja) * | 2006-10-12 | 2015-05-20 | アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | 複合薬剤 |
| TWI664965B (zh) * | 2015-06-22 | 2019-07-11 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法 |
| US20210078970A1 (en) * | 2019-08-30 | 2021-03-18 | Risen (Suzhou) Pharma Tech Co., Ltd. | Prodrugs of the tyrosine kinase inhibitor for treating cancer |
| WO2021035360A1 (en) * | 2019-08-30 | 2021-03-04 | Risen (Suzhou) Pharma Tech Co., Ltd. | Prodrugs of the tyrosine kinase inhibitor for treating cancer |
| CN112442010B (zh) * | 2019-08-30 | 2023-10-03 | 润佳（苏州）医药科技有限公司 | 一类前药化合物及其在治疗癌症方面的应用 |
-
2022
- 2022-10-14 CN CN202280066784.0A patent/CN118119599A/zh active Pending
- 2022-10-14 CA CA3232086A patent/CA3232086A1/en active Pending
- 2022-10-14 JP JP2024519989A patent/JP2024537839A/ja active Pending
- 2022-10-14 WO PCT/US2022/046750 patent/WO2023064578A1/en not_active Ceased
- 2022-10-14 AU AU2022362310A patent/AU2022362310A1/en active Pending
- 2022-10-14 US US18/706,306 patent/US20250092013A1/en active Pending
- 2022-10-14 MX MX2024003968A patent/MX2024003968A/es unknown
- 2022-10-14 EP EP22881846.4A patent/EP4416132A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024537839A (ja) | 2024-10-16 |
| US20250092013A1 (en) | 2025-03-20 |
| EP4416132A1 (en) | 2024-08-21 |
| WO2023064578A1 (en) | 2023-04-20 |
| CN118119599A (zh) | 2024-05-31 |
| MX2024003968A (es) | 2024-04-29 |
| EP4416132A4 (en) | 2025-09-03 |
| AU2022362310A1 (en) | 2024-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108601725B (zh) | 形状改变的药物递送装置和方法 | |
| KR102039468B1 (ko) | 의료용 유기젤 방법 및 조성물 | |
| EP3324902B1 (en) | Coated punctal plug | |
| CN104363924B (zh) | 用于递送hif‑1抑制剂的控制释放调配物 | |
| KR20170117384A (ko) | 히드로겔 약물 전달 임플란트 | |
| US20180333282A1 (en) | Extra luminal scaffold | |
| WO2016060925A1 (en) | Ocular gels or hydrogels and microinjectors | |
| CN111481513A (zh) | 缓释微球药物递送系统及其制备方法 | |
| US20250092013A1 (en) | Prodrugs of axitinib | |
| US20180008718A1 (en) | Compositions for the sustained release of anti-glaucoma agents to control intraocular pressure | |
| WO2017015616A1 (en) | Ocular protein delivery | |
| WO2024081410A1 (en) | Prodrugs, formulations and methods thereof | |
| US12453724B2 (en) | Ocular implant containing a tyrosine kinase inhibitor | |
| CN1665550A (zh) | 输送和释放药物活性剂的植入物及其制备方法 | |
| JP2022501365A (ja) | ドラッグデリバリーのための多孔質生体吸収性放射線不透過性塞栓ミクロスフェア | |
| US20230241055A1 (en) | Hydrophilic Degradable Microspheres for Delivering Buprenorphine | |
| US20260048008A1 (en) | Organogels for sustained drug delivery, methods of preparation and use thereof | |
| HK40115702A (zh) | 原位形成的具有共价键的单一溶液水凝胶、组成设计和使用该水凝胶的医疗程序 | |
| WO2026107180A1 (en) | Implant injector device | |
| KR20250160197A (ko) | 폴리(에틸렌 글리콜) 기반 덴드리머-유사 초분지형 거대분자, 이의 제조 방법 및 용도 | |
| CN118591369A (zh) | 挤出式眼部插入物或植入物及其方法 | |
| HK1261346A1 (en) | Shape changing drug delivery devices and methods | |
| Kurniawansyah et al. | INTERNATIONAL RESEARCH JOURNAL OF PHARMACY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R00 | Party data change recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R113 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF ADDRESS OR METHOD OF CORRESPONDENCE REQUEST RECEIVED Effective date: 20240731 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241004 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241004 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241004 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D120 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: VOLUNTARY SUBMISSION OF PRIOR ART RECEIVED Effective date: 20250811 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D123 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIOR ART DISCLOSURE DETERMINED COMPLIANT Effective date: 20250815 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250815 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250815 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251006 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251006 |
|
| R18 | Changes to party contact information recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R18-R143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF ADDRESS REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260316 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260316 |